Urol. praxi. 2021;22(2):97-98 | DOI: 10.36290/uro.2021.011

Progression of prostate cancer after radical prostatectomy despite undetectable PSA levels

MUDr. Alexandra Jarošová, MUDr. Vladimír Študent, Ph.D., ml.
Urologická klinika FN, Olomouc

Currently, prostate cancer is the third most common cancer disease in men in the Czech Republic and the second most common tumour found in men worldwide. Its incidence increases annually. Every year, diagnostic and treatment algorithms for prostate cancer are updated which take into account the rate of local tumour progression, its grade of histological differentiation, and the degree of metastatic spread. In the case of prostate cancer, the skeleton alone or the skeleton in combination with metastatic involvement of the iliac and/or para-aortic nodes are the most common sites of distant metastases. So far, only a small number of lung metastases of prostate cancer have been reported in the literature; in addition, they typically presented synchronously with bone metastases. Moreover, their occurrence correlated with an aggressive histological tumour subtype (a Gleason score of 8 and higher) and PSA elevation. This case is rare due to the fact that a solitary lung metastasis of prostate cancer was found in a patient with undetectable PSA levels and a Gleason score of 6 with exclusion of generalization to other sites.

Keywords: prostate cancer, radical prostatectomy, solitary lung metastasis, undetectable PSA levels, generalization, robotic radical prostatectomy.

Received: March 3, 2021; Revised: March 3, 2021; Accepted: March 4, 2021; Prepublished online: March 4, 2021; Published: June 2, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jarošová A, Študent V. Progression of prostate cancer after radical prostatectomy despite undetectable PSA levels. Urol. praxi. 2021;22(2):97-98. doi: 10.36290/uro.2021.011.
Download citation

References

  1. Tohfe M, Baki SA, Saliba W, et al. Metastatic prostate adenocarcinoma presenting with pulmonary symptoms: a case report and review of the literature. Cases J 2008; 1(1): 316. Published 2008 Nov 17. doi: 10.1186/1757-1626-1-316. Go to original source... Go to PubMed...
  2. Gago JP, Câmara G, Dionísio J, Opinião A. Pulmonary metastasis as sole manifestation of relapse in previously treated localised prostate cancer: three exceptional case reports. Ecancermedicalscience 2016; 10: 645. Published 2016 Jun 7. doi: 10.3332/ecancer.2016.645. Go to original source... Go to PubMed...
  3. Mortier D, Baten E, Vandeurzen K, van Renterghem K. The Benefit of a Surgical Resection of a Solitary Pulmonary Metastasis of Prostate Cancer after Radical Prostatectomy. Curr Urol 2017; 10(4): 210-212. doi: 10.1159/000447182. Go to original source... Go to PubMed...
  4. Wallis CJ, English JC, Goldenberg SL. The role of resection of pulmonary metastases from prostate cancer: a case report and literature review. Can Urol Assoc J 2011; 5(6): E104-E108. doi: 10.5489/cuaj.10136. Go to original source... Go to PubMed...
  5. Leibovici D, Spiess PE, Agarwal PK, et al. Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level. Cancer 2007; 109(2): 198-204. doi: 10.1002/cncr.22372. Go to original source... Go to PubMed...
  6. Prostate cancer. [online]. Dostupné z https://uroweb.org/guideline/prostate-cancer/.Novotvary 2016 ČR. [online]. Dostupné z https://uzis.cz/sites/default/files/knihovna/novotvary2016.pdf.




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.